Urine Detection of EGFR T790M Mutation in Non-Small-Cell Lung Cancer: An Outcomes and Total Cost of Care Analysis

被引：1
|
作者：
Sands, Jacob [1 ]
Hornberger, John [2 ]
机构：
[1] Lahey Hosp & Med Ctr, Oncol, Burlington, MA USA
[2] Cedar Associates Llc, Menlo Pk, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
NSCLC; T790M; liquid biopsy; Health Economics;
D O I：
10.1016/j.jtho.2016.11.1677
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02b010
引用
收藏
页码：S1191 / S1191
页数：1
相关论文
共 50 条
  • [21] Mixed Response of Non-Small Cell Lung Cancer Harboring the EGFR T790M Mutation to Osimertinib
    Shinno, Y.
    Goto, Y.
    Sato, J.
    Morita, R.
    Matsumoto, Y.
    Murakami, S.
    Kanda, S.
    Horinouchi, H.
    Fujiwara, Y.
    Yamamoto, N.
    Ohe, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2145 - S2145
  • [22] ROR1 as a novel therapeutic target for EGFR-mutant non-small-cell lung cancer patients with the EGFR T790M mutation
    Karachaliou, Niki
    Gimenez-Capitan, Ana
    Drozdowskyj, Ana
    Viteri, Santiago
    Moran, Teresa
    Carcereny, Enric
    Massuti, Bartomeu
    Vergnenegre, Alain
    de Marinis, Filippo
    Angel Molina, Miguel
    Teixido, Cristina
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (03) : 122 - 130
  • [23] Does T790M Disappear? Successful Gefitinib Rechallenge After T790M Disappearance in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer
    Hata, Akito
    Katakami, Nobuyuki
    Kaji, Reiko
    Fujita, Shiro
    Imai, Yukihiro
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (03) : E27 - E29
  • [24] Plasma ctDNA analysis for detection of EGFR T790M mutation in patients (pts) with EGFR mutation-positive advanced non-small cell lung cancer (aNSCLC)
    Jenkins, S.
    Yang, J.
    Ramalingam, S.
    Yu, K.
    Patel, S.
    Weston, S.
    Lawrance, R.
    Cantarini, M.
    Janne, P.
    Mitsudomi, T.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S153 - S154
  • [25] EGFR T790M Mutation A Double Role in Lung Cancer Cell Survival?
    Suda, Kenichi
    Onozato, Ryoichi
    Yatabe, Yasushi
    Mitsudomi, Tetsuya
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (01) : 1 - 4
  • [26] Detection of EGFR T790M Mutation in Pericardial Effusion from a Non-Small Cell Lung Cancer Patient with Erlotinib Therapy
    Sakai, Asao
    Kasahara, Kazuo
    Sone, Takashi
    CASE REPORTS IN ONCOLOGY, 2013, 6 (01): : 15 - 20
  • [27] Poor Prognosis With Coexistence Of EGFR T790M Mutation And Common EGFR-Activating Mutation In Non- Small Cell Lung Cancer
    Gao, Xuejuan
    Zhao, Yanfeng
    Bao, Yi
    Yin, Wei
    Liu, Liyu
    Liu, Ruchuan
    Yu, Zhengquan
    Zhou, Xiao
    Shuai, Jianwei
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 9621 - 9630
  • [28] Noninvasive Detection of EGFR T790M in Gefitinib or Erlotinib Resistant Non-Small Cell Lung Cancer
    Kuang, Yanan
    Rogers, Andrew
    Yeap, Beow Y.
    Wang, Lilin
    Makrigiorgos, Mike
    Vetrand, Kristi
    Thiede, Sara
    Distel, Robert J.
    Jaenne, Pasi A.
    CLINICAL CANCER RESEARCH, 2009, 15 (08) : 2630 - 2636
  • [29] ROR1 AS A NOVEL THERAPEUTIC TARGET FOR EGFR-MUTANT NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS WITH THE EGFR T790M MUTATION
    Karachaliou, Niki
    Drozdowskyj, Ana
    Costa, Carlota
    Angel Molina-Vila, Miguel
    Gimenez-Capitan, Ana
    Vergnenegre, Alain
    Massuti, Bartomeu
    Moran, Teresa
    Majem, Margarita
    Felip, Enriqueta
    Carcereny, Enric
    Garcia-Campelo, Rosario
    Viteri, Santiago
    Heidecke, Cordula
    Estrada-Tejedor, Roger
    Teixido, Jordi
    Bivona, Trever
    Giannikopoulos, Petros
    Ono, Mayumi
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1048 - S1048
  • [30] An evaluation of aumolertinib for the treatment of EGFR T790M mutation-positive non-small cell lung cancer
    Wang, Jingyi
    Wu, Lin
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (06) : 647 - 652
12345